Literature DB >> 29446528

Can CT imaging features of ground-glass opacity predict invasiveness? A meta-analysis.

Jian Dai1, Guoyou Yu2, Jianqiang Yu3.   

Abstract

BACKGROUND: A meta-analysis was conducted to investigate the diagnostic performance of computed tomography (CT) imaging features of ground-glass opacity (GGO) to predict invasiveness.
METHODS: Two reviewers independently searched PubMed, Medline, Web of Science, Cochrane Embase and CNKI for relevant studies. CT imaging signs of bubble lucency, speculation, lobulated margin, and pleural indentation were used as diagnostic references to discriminate pre-invasive and invasive disease. The sensitivity, specificity, diagnostic odds ratio (DOR), summary receiver operating characteristic (SROC) curves, and the area under the SROC curve (AUC) were calculated to evaluate diagnostic efficiency.
RESULTS: Twelve studies were finally included. Diagnostic performance ranged from 0.41 to 0.52 for sensitivity and 0.56 to 0.63 for specificity. The diagnostic positive and negative likelihood ratios ranged from 1.03 to 2.13 and 0.52 to 1.05, respectively. The DORs of the GGO CT features for discriminating invasive disease ranged from 1.02 to 4.00. The area under the ROC curve was also low, with a range of 0.60 to 0.67 for discriminating pre-invasive and invasive disease.
CONCLUSION: The diagnostic value of a single CT imaging sign of GGO, such as bubble lucency, speculation, lobulated margin, or pleural indentation is limited for discriminating pre-invasive and invasive disease because of low sensitivity, specificity, and AUC.
© 2018 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Bubble lucency; GGO; lobulated margin; pleural indentation; spiculation

Mesh:

Year:  2018        PMID: 29446528      PMCID: PMC5879054          DOI: 10.1111/1759-7714.12604

Source DB:  PubMed          Journal:  Thorac Cancer        ISSN: 1759-7706            Impact factor:   3.500


Introduction

Lung cancer is the most commonly diagnosed malignant cancer and one of the leading causes of cancer‐related death globally.1 Epidemiology studies have revealed that although squamous cell carcinoma was initially the most common pathological subtype, adenocarcinoma has now become the dominant subtype.2 In 2011, the International Association for the Study of Lung Cancer (IASLC), the American Thoracic Society (ATS), and the European Respiratory Society (ERS) jointly published a new lung adenocarcinoma classification system. Bronchioloalveolar carcinoma was abandoned and the concept of minimally invasive adenocarcinoma was first introduced. Generally, pre‐invasive ground‐glass opacity (GGO) was included as atypical adenomatous hyperplasia (AAH) and adenocarcinoma in situ (AIS). Minimally invasive adenocarcinoma (MIA) and invasive adenocarcinoma were categorized as invasive disease. It is believed that the change from AAH to MIA is a continuous process. The five‐year survival rate has been reported at almost 100% for AAH, AIS, and MIA patients;3 however, the long‐term survival rate of patients with invasive adenocarcinoma remains poor. Therefore, early diagnosis of invasive adenocarcinoma and distinguishing between pre‐invasive and invasive lesions is important for the clinical management of GGO. Clinically, high resolution CT (HRCT) examination is routinely performed to assess GGO lesions.4 Several imaging features, such as bubble lucency, speculation, lobulated margin, and pleural indentation, were commonly used to predict pathology type. However, the discrimination power of HRCT imaging features to discern pre‐invasive from invasive lesions is unclear. Therefore, we evaluated the diagnostic performance of CT imaging features of GGO to predict invasiveness.

Methods

Electronic publication search

Two reviewers independently searched PubMed, Medline, Web of Science, Cochrane Embase, and CNKI for relevant studies. The search terms included: computed tomography, ground‐glass nodule, ground‐glass opacity, atypical adenomatous hyperplasia, adenocarcinoma in situ, and minimally invasive adenocarcinoma. References of the included studies were also screened to locate additional relevant publications.

Inclusion and exclusion criteria

The inclusion criteria were: (i) studies related to CT imaging features to predict invasive and pre‐invasive disease; (ii) pathology or cytology examinations were used as the gold standard of diagnosis; and (iii) adequate data could be extracted from the original publication. Exclusion criteria: (i) duplicate publications or data; (ii) case reports or reviews; (iii) the original study did not provide a diagnostic gold standard; (iv) publication in languages other than English or Chinese; and (v) insufficient data available in the original publication.

Data extraction

Two reviewers independently reviewed the full text of each included study. Disagreement was resolved by discussion or consultation with a third reviewer. The first and corresponding author names, publication year and journal, the country in which the study was performed, GGO type, and sample size, were extracted. The number of GGO lesions located using CT imaging signs of bubble lucency, speculation, lobulated margin, and pleural indentation in pre‐invasive and invasive GGO were also extracted. All data were cross‐checked.

Statistical analysis

Diagnostic sensitivity and specificity were calculated using the formulas: sensitivity = true positive/(true positive + false negative); and specificity = true negative/(true negative + false positive). The area under the receiver operating characteristic (ROC) curve was used to evaluate the feasibility of CT imaging features for the diagnosis of pre‐invasive and invasive GGO. Publication bias was evaluated using Deek's funnel plot and Egger's line regression test. Two‐tailed P values of < 0.05 were considered statistically significant. All statistical analysis was performed using Stata version 12.0 (http://www.stata.com; Stata Corporation, College Station, TX, USA.)

Results

General features of the included studies

Initially, 1128 publications were identified; however, after applying the inclusion criteria, twelve studies were finally included in the meta‐analysis (Fig 1).5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16 The characteristics of the included studies are shown in Table 1.
Figure 1

Publication screening flow chart.

Table 1

Main characteristics of the included studies

StudyYearCountrySample sizeInvasivePre‐invasiveGGO type
Lee et al.5 2013Korea20816048pGGO/mGGO
Gao et al.6 2014China977324pGGO
Zhang et al.7 2014China533815pGGO/mGGO
Pan et al.8 2014China735221pGGO
Jin et al.9 2014China947321pGGO
Liu et al.10 2015China1056243pGGO
Shi et al.11 2016China824339pGGO/mGGO
Pan et al.12 2016China992079pGGO
Li et al.13 2016China802159pGGO/mGGO
Lu et al.14 2017China412417pGGO/mGGO
Tang et al.15 2017China342014pGGO
Jing et al.16 2017China1033667pGGO

mGGO, mixed ground‐glass opacity; pGGO, pure GGO.

Publication screening flow chart. Main characteristics of the included studies mGGO, mixed ground‐glass opacity; pGGO, pure GGO.

Pooled diagnostic sensitivity and specificity

The diagnostic sensitivity and specificity using bubble lucency as a reference of invasive GGO discrimination was 0.52 (0.47–0.57) and 0.63 (0.58–0.67) respectively; For speculation, lobulated margin, and pleural indentation, the diagnostic sensitivity was 0.52 (0.46–0.58), 0.41(0.35–0.46), and 0.46 (0.41–0.51); and the specificity was 0.58 (0.54–0.60), 0.56 (0.51–0.60), and 0.60 (0.56–0.65), respectively (Table 2).
Table 2

Pooled diagnostic sensitivity and specificity for CT imaging features of GGO (95% confidence interval)

Diagnostic performanceBubble lucencySpeculationLobulated marginPleural indentation
Sensitivity0.52 (0.47–0.57)0.52 (0.46–0.58)0.41 (0.35–0.46)0.46 (0.41–0.51)
Specificity0.63 (0.58–0.67)0.58 (0.54–0.60)0.56 (0.51–0.60)0.60 (0.56–0.65)

CT, computed tomography; GGO, ground‐glass opacity.

Pooled diagnostic sensitivity and specificity for CT imaging features of GGO (95% confidence interval) CT, computed tomography; GGO, ground‐glass opacity.

Positive and negative likelihood and diagnostic odds ratios

The positive and negative likelihood ratios were 1.36 (1.20–1.54) and 0.79 (0.69–0.90) for bubble lucency; 1.57 (1.16–2.13) and 0.71 (0.52–0.95) for speculation; 1.44 (1.12–1.84) and 0.80 (0.64–1.01) for lobulated margin; and 1.45 (1.03–2.05) and 0.88(0.73–1.05) for pleural indentation, respectively (Table 3). The diagnostic odds ratios for bubble lucency, speculation, lobulated margin, and pleural indentation for discriminating invasive disease were 2.27 (1.59–3.24), 2.96 (1.54–5.67), 2.27 (1.29–4.00), and 1.90 (1.02–3.55), respectively.
Table 3

Pooled likelihood ratios and DOR for CT imaging features of GGO (95% confidence interval)

Diagnostic performanceBubble lucencySpeculationLobulated marginPleural indentation
+lr1.36 (1.20–1.54)1.57 (1.16–2.13)1.44 (1.12–1.84)1.45 (1.03–2.05)
−lr0.79 (0.69–0.90)0.71 (0.52–0.95)0.80 (0.64–1.01)0.88 (0.73–1.05)
DOR2.27 (1.59–3.24)2.96 (1.54–5.67)2.27 (1.29–4.00)1.90 (1.02–3.55)

+lr, positive likelihood ratio; ‐lr, negative likelihood ratio; CT, computed tomography; DOR, diagnostic odds ratio; GGO, ground‐glass opacity.

Pooled likelihood ratios and DOR for CT imaging features of GGO (95% confidence interval) +lr, positive likelihood ratio; ‐lr, negative likelihood ratio; CT, computed tomography; DOR, diagnostic odds ratio; GGO, ground‐glass opacity.

Pooled receiver operating characteristic curves

The pooled ROC curve was drawn by sensitivity against 1‐specificity using Stata version 12.0. The area under the ROC curve (AUC) values were 0.64, 0.67, 0.64, and 0.60 for bubble lucency, speculation, lobulated margin, and pleural indentation of GGO for discriminating pre‐invasive and invasive disease, respectively (Fig 2).
Figure 2

Pooled receiver operating characteristic (ROC) curves for computed tomography imaging signs to discriminate pre‐invasive and invasive disease: (a) bubble lucency () study estimate, () Summary point, () HSROC curve, () 95% confidence region, and () 95% prediction region; (b) speculation () study estimate, () Summary point, () HSROC curve, () 95% confidence region, and () 95% prediction region; (c) lobulated margin () study estimate, () Summary point, () HSROC curve, () 95% confidence region, and () 95% prediction region; and (d) pleural indentation () study estimate, () Summary point, () HSROC curve, () 95% confidence region, and () 95% prediction region. HSROC, hierarchical summary receiver operating characteristic.

Pooled receiver operating characteristic (ROC) curves for computed tomography imaging signs to discriminate pre‐invasive and invasive disease: (a) bubble lucency () study estimate, () Summary point, () HSROC curve, () 95% confidence region, and () 95% prediction region; (b) speculation () study estimate, () Summary point, () HSROC curve, () 95% confidence region, and () 95% prediction region; (c) lobulated margin () study estimate, () Summary point, () HSROC curve, () 95% confidence region, and () 95% prediction region; and (d) pleural indentation () study estimate, () Summary point, () HSROC curve, () 95% confidence region, and () 95% prediction region. HSROC, hierarchical summary receiver operating characteristic.

Publication analysis

Publication bias of GGO features in CT imaging to predict invasiveness was assessed by Deeks’ funnel plot and Egger's line regression test (Fig 3). No significant bias for bubble lucency (P = 0.36), speculation (P = 0.27), lobulated margin (P = 0.92), or pleural indentation (P = 0.78) was observed (Table 4).
Figure 3

Publication bias evaluated by Deeks’ funnel plot for computed tomography features: (a) bubble lucency () Study, and () Regression Line; (b) speculation () Study, and () Regression Line; (c) lobulated margin () Study, and () Regression Line; and (d) pleural indentation () Study, and () Regression Line.

Table 4

Publication bias evaluation for CT features

CT featuresCoefficientSE t P 95% CI of coefficient
Bubble lucency5.225.450.960.36−7.10–17.54
Speculation−11.9510.25−1.170.27−35.14–11.23
Lobulated margin1.0710.820.100.92−23.88–26.03
Pleural indentation0.361.250.290.78−2.53–3.25

CI, confidence interval; CT, computed tomography; SE, standard error.

Publication bias evaluated by Deeks’ funnel plot for computed tomography features: (a) bubble lucency () Study, and () Regression Line; (b) speculation () Study, and () Regression Line; (c) lobulated margin () Study, and () Regression Line; and (d) pleural indentation () Study, and () Regression Line. Publication bias evaluation for CT features CI, confidence interval; CT, computed tomography; SE, standard error.

Discussion

Early stage lung adenocarcinoma is mainly expressed as GGO on HRCT. GGO is a non‐specific finding on CT scans that indicates a partial filling of air spaces in the lungs by exudate or transudate, as well as interstitial thickening or the partial collapse of lung alveoli.17 According to its composition, GGO is generally divided into pure GGO (pGGO) or mixed GGO (mGGO). It has been reported that about 18% of pGGO and 63% of mGGO can develop into malignant lesions.18 Sukki et al. found that about 59% of stable pGGOs developed into AIS or MIA.19 Studies have proven that the process from AAH to invasive adenocarcinoma is continuous and may take many years. With developments in CT examination technology, such as the application of low‐dose mass screening and HRCT, GGO is now more commonly detected clinically.20, 21 The five‐year survival rate has been reported at almost 100% for AAH, AIS, and MIA patients;3 however, the long‐term survival rate of patients with invasive adenocarcinoma remains poor.22, 23, 24 Intensive follow‐up and CT scan examinations increase the cost of medical care and cause unnecessary patient concern. Thus, how to identify benign and malignant and pre‐invasive and invasive lesions remains a challenge for clinicians and radiologists. Previous studies have evaluated the diagnostic performance of CT imaging features of GGO for discriminating pre‐invasive and invasive lesions; however, the results have been inconsistent or inconclusive.5, 10, 11 In the present study, we examined the results of previous studies of GGO CT imaging features and found low differential diagnostic performance, ranging from 0.41 to 0.52 for sensitivity and 0.56 to 0.63 for specificity. The AUC was also low, with a range of 0.60 to 0.67. These results indicate that the diagnostic performance of a single CT imaging sign for GGO is limited for discriminating pre‐invasive and invasive disease because of low sensitivity, specificity, and AUC. There are some limitations to the present meta‐analysis: (i) the general quality of the included studies was relatively poor; (ii) only studies published in English or Chinese were included; and (iii) pooled combined CT imaging features, such as speculation, lobulated margin, and pleural indentation, were not calculated. Our results indicate that a single CT imaging feature is inadequate to discriminate pre‐invasive from invasive disease in cases of GGO. A quantitative diagnostic mathematical model combining CT imagining features is needed to reevaluate diagnostic performance.

Disclosure

No authors report any conflict of interest.
  15 in total

1.  Lung cancer screening using low-dose high-resolution CT scanning in a high-risk workforce: 3500 nuclear fuel workers in three US states.

Authors:  Albert Miller; Steven Markowitz; Amy Manowitz; Jeffrey A Miller
Journal:  Chest       Date:  2004-05       Impact factor: 9.410

Review 2.  Management of ground-glass opacities: should all pulmonary lesions with ground-glass opacity be surgically resected?

Authors:  Yoshihisa Kobayashi; Tetsuya Mitsudomi
Journal:  Transl Lung Cancer Res       Date:  2013-10

3.  [CT diagnosis of different pathological types of ground-glass nodules].

Authors:  Feng Gao; Xiao-Jun Ge; Ming Li; Yan Chen; Fanzhen Lyu; Yanqing Hua; Qingguo Ren; Lin Qi
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2014-03

Review 4.  Ground-Glass Opacity Lung Nodules in the Era of Lung Cancer CT Screening: Radiology, Pathology, and Clinical Management.

Authors:  Jesper Holst Pedersen; Zaigham Saghir; Mathilde Marie Winkler Wille; Laura Hohwü Thomsen; Birgit Guldhammer Skov; Haseem Ashraf
Journal:  Oncology (Williston Park)       Date:  2016-03       Impact factor: 2.990

5.  Multiple focal pure ground-glass opacities on high-resolution CT images: Clinical significance in patients with lung cancer.

Authors:  Shin Tsutsui; Kazuto Ashizawa; Kazunori Minami; Tsutomu Tagawa; Takeshi Nagayasu; Tomayoshi Hayashi; Masataka Uetani
Journal:  AJR Am J Roentgenol       Date:  2010-08       Impact factor: 3.959

6.  CT findings of persistent pure ground glass opacity: can we predict the invasiveness?

Authors:  Li-Heng Liu; Ming Liu; Ran Wei; Er-Hu Jin; Yu-Hui Liu; Liang Xu; Wen-Wu Li; Yong Huang
Journal:  Asian Pac J Cancer Prev       Date:  2015

7.  Management of multiple pure ground-glass opacity lesions in patients with bronchioloalveolar carcinoma.

Authors:  Hong Kwan Kim; Yong Soo Choi; Jhingook Kim; Young Mog Shim; Kyung Soo Lee; Kwhanmien Kim
Journal:  J Thorac Oncol       Date:  2010-02       Impact factor: 15.609

8.  Invasive pulmonary adenocarcinomas versus preinvasive lesions appearing as ground-glass nodules: differentiation by using CT features.

Authors:  Sang Min Lee; Chang Min Park; Jin Mo Goo; Hyun-Ju Lee; Jae Yeon Wi; Chang Hyun Kang
Journal:  Radiology       Date:  2013-03-06       Impact factor: 11.105

9.  Significance of ground-glass opacity on HRCT in long-term follow-up of patients with systemic sclerosis.

Authors:  Rosita M Shah; Sergio Jimenez; Richard Wechsler
Journal:  J Thorac Imaging       Date:  2007-05       Impact factor: 3.000

Review 10.  Lung Cancer Statistics.

Authors:  Lindsey A Torre; Rebecca L Siegel; Ahmedin Jemal
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

View more
  9 in total

1.  The natural course of incidentally detected, small, subsolid lung nodules-is follow-up needed beyond current guideline recommendations?

Authors:  Benedikt H Heidinger; Mario Silva; Constance de Margerie-Mellon; Paul A VanderLaan; Alexander A Bankier
Journal:  Transl Lung Cancer Res       Date:  2019-12

2.  Metabolic profiles of serum samples from ground glass opacity represent potential diagnostic biomarkers for lung cancer.

Authors:  Jian-Zhong Li; Yuan-Yang Lai; Jian-Yong Sun; Li-Na Guan; Hong-Fei Zhang; Chen Yang; Yue-Feng Ma; Tao Liu; Wen Zhao; Xiao-Long Yan; Shao-Min Li
Journal:  Transl Lung Cancer Res       Date:  2019-08

3.  Investigating the association between ground-glass nodules glucose metabolism and the invasive growth pattern of early lung adenocarcinoma.

Authors:  Xiaoliang Shao; Xiaonan Shao; Rong Niu; Zhenxing Jiang; Mei Xu; Yuetao Wang
Journal:  Quant Imaging Med Surg       Date:  2021-08

4.  Establishment and verification of a prediction model based on clinical characteristics and positron emission tomography/computed tomography (PET/CT) parameters for distinguishing malignant from benign ground-glass nodules.

Authors:  Rong Niu; Xiaonan Shao; Xiaoliang Shao; Zhenxing Jiang; Jianfeng Wang; Yuetao Wang
Journal:  Quant Imaging Med Surg       Date:  2021-05

5.  Feasibility of electromagnetic navigation bronchoscopy-guided lung resection for pulmonary ground-glass opacity nodules.

Authors:  Zhe Piao; Sung Joon Han; Hyun Jin Cho; Min-Woong Kang
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 2.895

6.  Maximum Standardized Uptake Value of 18F-deoxyglucose PET Imaging Increases the Effectiveness of CT Radiomics in Differentiating Benign and Malignant Pulmonary Ground-Glass Nodules.

Authors:  Rong Niu; Jianxiong Gao; Xiaoliang Shao; Jianfeng Wang; Zhenxing Jiang; Yunmei Shi; Feifei Zhang; Yuetao Wang; Xiaonan Shao
Journal:  Front Oncol       Date:  2021-12-17       Impact factor: 6.244

7.  Identification of pathological subtypes of early lung adenocarcinoma based on artificial intelligence parameters and CT signs.

Authors:  Weiyuan Fang; Guorui Zhang; Yali Yu; Hongjie Chen; Hong Liu
Journal:  Biosci Rep       Date:  2022-01-28       Impact factor: 3.840

8.  A nomogram to predict invasiveness in lung adenocarcinoma presenting as ground glass nodule.

Authors:  Nan Zhang; Jun-Feng Liu; Ya-Ning Wang; Li Yang
Journal:  Transl Cancer Res       Date:  2020-03       Impact factor: 1.241

9.  Invasive Prediction of Ground Glass Nodule Based on Clinical Characteristics and Radiomics Feature.

Authors:  Hui Zheng; Hanfei Zhang; Shan Wang; Feng Xiao; Meiyan Liao
Journal:  Front Genet       Date:  2022-01-06       Impact factor: 4.599

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.